Thank You 2023 Sponsors and Exhibitors!

-

 

Thank You Sponsors & Exhibitors


The 52nd Annual Scientific Meeting of the International Society for Experimental Hematology meeting is taking place now in New York City, United States. The exciting program (https://www.iseh.org/ISEH2023) includes career and technology sessions, as well as talks and poster presentations from trainees, new investigators and leaders in the field.
On behalf of the ISEH Board of Directors, volunteers and staff, we'd like to thank our 2023 sponsors and exhibitors, seen below. We hope to see you all again in 2024!


Funding for this conference was made possible (in part) by R13HL170705 from the National Heart Lung and Blood Institute (NHLBI). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 

This program is supported by an independent medical education grant from Pfizer.

Platinum

 

Gold

 

Silver

 

Bronze

Educational Supporters

 
 

Comments

Post a Comment

Popular posts from this blog

Transition from academia to industry: An interview with Elizabeth Paik

-
Image
We have all read many articles about the possible career choices of a scientist. The usual dilemma is between industry and academia. We have talked about this in previous blogs but the more information we get the easier it is to make a wise choice. Of course we all have opinions about the pros and cons of such a choice but what I always find best is to ask people who have experienced both. That is why I turned to an old colleague and friend, Elizabeth Paik, and asked her some questions regarding her experiences in both academia and industry. Can you describe to us your scientific career? I started my career at Harvard Medical School, as a graduate student in Dr. Len Zon's laboratory. My thesis work focused on understanding a role of CDX transcription factors during embryonic hematopoiesis. Through ChIP-seq, knockdown and overexpression studies in zebrafish, I showed CDX transcription factors control expression of hematopoietic transcription factors - SCL and LMO2. Towards the...
Read more

ISEH 2025 Society Award Winners

-
Image
  On behalf of the Awards Committee, ISEH would like to congratulate the recipients of the 2025 ISEH Society Awards which will be presented at the  ISEH 54th Annual Scientific Meeting . Donald Metcalf Award Winner - Constanze Bonifer The recipient of the 2025 Donald Metcalf Award is Dr. Constanze ‘Conny’ Bonifer, for her outstanding work in the fields of epigenetic and gene regulatory processes regulating blood cell development and differentiation, and how these processes go astray in the development of blood cancer. Dr. Bonifer has been a pioneer and world leader in these areas and a source of inspiration and guidance for many scientists working in experimental hematology.  Dr. Bonifer started her scientific career in Germany where she completed her BSc in Cologne and her PhD in Heidelberg. After a postdoctoral fellowship at the Karolinska Institute, Stockholm, Sweden and the National Institute of Medical Research, London, UK, Dr. Bonifer returned to Germany as an Assist...
Read more

New Culture Methods in Experimental Hematology

-
Image
  The ability to expand hematopoietic stem cells (HSCs) ex vivo has broad clinical and translational potential, and there has been substantial progress in the development of advanced culture systems. Experimental Hematology offers a timely special issue “New Culture Methods in Experimental Hematology”, and two of the reviews specifically address the bone marrow (BM) microenvironment and ex vivo HSC expansion technologies respectively. Busch et al[1] provide a comprehensive summary of the BM microenvironment, covering cellular as well as extracellular components and how these interact. The complexity and challenges of three-dimensional approaches to model the BM niche are described.  The review by Meaker and Wilkinson[2] provides an in-depth analysis of ex vivo expansion of HSCs. This is a key technology for basic research questions and has the potential to improve HSC transplantation and gene therapies in the future. Along these lines there have been important steps taken to a...
Read more